News | September 11, 2012

Noninvasive FFR-CT Identifies Flow-Restricting Coronary Artery Blockages

DeFACTO study shows accuracy of fractional flow reserve computed tomography in relation to catheter-based FFR

September 11, 2012 — Data presented at the 2012 European Society of Cardiology (ESC) Congress in Munich, Germany, from the prospective Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography (DeFACTO) study show that, when compared to standard coronary angiography, the noninvasive assessment of fractional flow reserve by computed tomography (FFR-CT) provides a more accurate determination of which lesions require invasive evaluation.[1] The results of the study were presented by James K. Min, director of cardiac imaging research and co-director of cardiac imaging at department of medicine, imaging and biomedical sciences at Cedars-Sinai Heart Institute in Los Angeles.

The study compared the ability of FFR-CT and computed tomography (CT) alone to identify flow-restricting lesions by assessment of fractional flow reserve (FFR), a measurement recognized as the standard for determining which lesions require treatment.[2] DeFACTO enrolled 252 stable patients with suspected coronary artery disease at 17 centers in five countries. All patients underwent CT, invasive coronary angiography, invasive FFR and subsequent FFR-CT analysis.

Results showed that FFR-CT was better able to identify flow-restricting arterial lesions than CT alone. The per-patient sensitivity and specificity of FFR-CT were also higher than CT alone using an area under the curve (AUC) analysis (AUC 0.81 vs. 0.68, p=0.0002).

The improvement in diagnostic performance was found greatest in arterial blockages of intermediate severity. In this set of patients, there was over a two-fold increase in test sensitivity, from 37 to 82 percent, with no loss of specificity. In these patients, the AUC improved from 0.53 for CT alone to 0.80 for FFR-CT (p=0.0002).

"One of the central challenges in taking care of patients with coronary artery disease is knowing which ones need further invasive evaluation for determining the need for coronary revascularization," said Min. "The results of the DeFACTO trial clearly demonstrate that when added to coronary CT angiographic findings, FFR-CT provides essential physiologic information as to which specific arterial blockages truly restrict blood flow to the heart and heighten patient risk.

"This is an exciting step forward for cardiology that could significantly improve how we guide patients towards the most effective and efficient care. Our findings also suggest that FFR-CT could be particularly useful for evaluating patients with arterial blockages of an intermediate severity, which are often the most difficult to assess noninvasively. This represents a large group of patients who unfortunately are often prone to frequent misdiagnosis. In addition, given the high negative predictive value of FFR-CT, it may serve as an effective 'gatekeeper' to further unnecessary invasive procedures."

For more information: www.escardio.org

References
1. The HeartFlow technology investigated in the study is a Web-based service that enables the computation of noninvasive FFR and thereby the identification of which lesions are causing ischemia. The technology computes FFR-CT from patient-specific 3-D computational models of the aorta, heart and coronary artery tree obtained from CT scan data, and results are transmitted via HeartFlow’s secure Web interface as an interactive report.
2. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI). Guidelines on Myocardial Revascularization. Eur Heart J 2010; 31: 2501-255.

Related Content

Coreline Soft Introduces AI Lung Segmentation Solution at RSNA 2018
News | Lung Cancer | December 10, 2018
December 10, 2018 — Korean image software company Coreline Soft Co. Ltd.
FDA Approves New Features for Planmed Verity Cone Beam CT Scanner
Technology | Computed Tomography (CT) | December 07, 2018
The U.S. Food and Drug Administration (FDA) issued an approval letter for the new features and intended uses of the...
Youth Football Changes Nerve Fibers in Brain

Statistically significant clusters (red-colored) showing group differences (Control vs. Football) in white matter strain along the primary (F1) and secondary (F2) fibers. While body of corpus callosum (BBC) showed relative shrinkage in Football group, the other clusters showed relative stretching of fibers. PCR: Posterior Corona Radiata, PLIC: Posterior Limb of Internal Capsule, SCR: Superior Corona Radiata, SLF: Superior Longitudinal Fasciculus, SCC: Splenium of Corpus Callosum. Image courtesy of Kim et al.

News | Neuro Imaging | December 07, 2018
Magnetic resonance imaging (MRI) scans show repetitive blows to the head result in brain changes among youth football...
YITU Releases AI-Based Cancer Screening Solutions at RSNA 2018
News | Artificial Intelligence | December 06, 2018
Chinese artificial intelligence (AI) healthcare company YITU healthcare released two brand-new products, Intelligent...
Guerbet Launches Multi-Use OptiVantage Contrast Media Injector in Europe
Technology | Contrast Media Injectors | December 05, 2018
Contrast agent company Guerbet recently announced that the OptiVantage multi-use contrast media injector is now CE...
GE Healthcare Unveils New Applications and Smart Devices Built on Edison Platform
Technology | Artificial Intelligence | December 05, 2018
GE Healthcare recently announced new applications and smart devices built on Edison – a platform that helps accelerate...
Fovia Launches F.A.S.T. AI Suite for PACS
Technology | Advanced Visualization | December 05, 2018
Fovia Inc. recently announced the release of a new artificial intelligence (AI) visualization platform, F.A.S.T. AI...
Infervision Introduces AI Capabilities for Chest CT Reading
Technology | Computer-Aided Detection Software | November 30, 2018
Big data and artificial intelligence (AI) company Infervision announced the launch of InferRead CT Chest, a new product...
NeuroLogica and MaxQ AI Announce Distribution Agreement
News | Stroke | November 30, 2018
Clinical diagnostics intelligence platform company MaxQ AI and Samsung NeuroLogica announced a distribution agreement...
Videos | Advanced Visualization | November 30, 2018
This is an example of the FDA-cleared OpenSight augmented reality (AR) system for surgical planning from NovaRad at t